Celiac Comprehensive Panel




Test Mnemonic

CELCMP

CPT Codes

  • 86364 - QTY (1)
  • 86258 - QTY (1)
  • 81382 - QTY (1)
  • 82784 - QTY (1)
  • 81382 - QTY (1)

Aliases

  • Deamidated Gliadin Peptide Antibody

Includes

  • Anti-Human Tissue Anti-Human Transglutaminase IgA
  • Total IgA
  • HLA-DQ2
  • HLA-DQ8
  • Gliadin IgA

Performing Laboratory

n/a


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
2 mLSerumSST (Gold) Refrigerated 
4 mL    whole blood

Alternate Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
2 mLSerumNo additive (Red) RefrigeratedThis assay requires multiple specimen types
7 mLWhole bloodACD A or B (Yellow) Ambient 

Stability

Environmental Condition Description
AmbientSerum: 1 day; Whole Blood: 1 week
RefrigeratedSerum: 7 days; Whole blood: 1 week
Frozen14 days, up to 2 freeze/thaw cycles

Days Performed

Mon - Fri

Turnaround Time

1 - 4 days

Methodology

Name Description
Enzyme-Linked Immunosorbent Assay (ELISA) 
Polymerase Chain Reaction (PCR) 
Sequence Specific Oligonucleotide Probe (SSOP) 
Immunoturbidometric Assay 

Reference Range

Gliad Deamidated IgA Qual
Sex Age From Age To Type Range Range Unit
       NormalNegative 
Gliadin IgA Ab
Sex Age From Age To Type Range Range Unit
       Normal<20Units
IgA
Sex Age From Age To Type Range Range Unit
   Months11 MonthsNormalless than 83mg/dL
 1 Years3 YearsNormal20 - 100mg/dL
 4 Years6 YearsNormal27 - 195mg/dL
 7 Years9 YearsNormal34 - 305mg/dL
 10 Years11 YearsNormal53 - 204mg/dL
 12 Years13 YearsNormal58 - 358mg/dL
 14 Years15 YearsNormal47 - 249mg/dL
 16 Years19 YearsNormal61 - 348mg/dL
 20 Years99 YearsNormal70 - 400mg/dL
Transglutaminase Ab, IgA
Sex Age From Age To Type Range Range Unit
       Normal<4.0Units
Transglutaminase IgA Qualitative
Sex Age From Age To Type Range Range Unit
       NormalNegative 

Clinical Info

Comprehensive panel of tests useful to screen patients suspected of celiac disease. This panel should not be the first choice in screening patients for celiac disease. Presence of celiac-specific alleles helps assess a patient's risk of developing celiac disease when serology is negative.

Clinical Limitation

Serum samples that are hemolyzed, lipemic, heat treated, bacterially contaminated or contain visible particulate should be avoided.